“Botox” has become the catch-all term for injectable wrinkle relaxers, the way “Kleenex” stands in for facial tissue. But Botox is actually one of several FDA-approved neuromodulators on the market, and the alternatives aren’t just cheaper imitations. Its relatives are distinct products with their own characteristics, and for many patients, one of them turns out to be the better fit. Here’s what you need to know about all three.
How Neuromodulators Work
Botox, Dysport, and Jeuveau all belong to the same class of treatment, as well as Daxxify and Xeomin. Each contains botulinum toxin type A, which temporarily relaxes the muscles responsible for dynamic wrinkles, the lines that form from repeated facial expressions like squinting, frowning, and raising your brows.
Common treatment areas include:
- Forehead lines: Horizontal creases that develop from raising the eyebrows
- Frown lines (glabellar lines): The vertical “11” lines between the brows
- Crow’s feet: The fine lines that fan out from the outer corners of the eyes
Results across all three products develop over a few days and typically last three to four months, at which point muscle activity gradually returns and retreatment maintains the effect.
Botox
Botox (onabotulinumtoxinA), made by Allergan, set the standard for neuromodulator treatments and has the longest track record of any product in this category. It earned FDA approval for cosmetic use in 2002 and has accumulated decades of clinical data and real-world use since then.
Botox works predictably and consistently across a wide range of patients. For many dermatologists and patients, that familiarity is itself a significant advantage. Dosing, placement, and expected outcomes are well established.
Dysport
Dysport (abobotulinumtoxinA), made by Galderma, uses a slightly different formulation of botulinum toxin that diffuses more broadly after injection. That diffusion characteristic makes it particularly well suited for larger treatment areas like the forehead, where a broader spread can produce a smooth, natural result with fewer injection points.
Jeuveau
Jeuveau (prabotulinumtoxinA), made by Evolus, received FDA approval in 2019 and markets itself specifically as a cosmetic-only neuromodulator. Its formulation closely resembles Botox, and clinical trials demonstrated comparable efficacy and safety. Some patients who have plateaued on Botox find that switching to Jeuveau delivers a refreshed response.
Daxxify
Daxxify (daxibotulinumtoxinA), made by Revance, earned FDA approval in 2022 and brought a notable distinction to the neuromodulator category: clinical trials demonstrated an average duration of six months, with some patients seeing results last up to nine months. Where most neuromodulators require treatment every three to four months, Daxxify suits patients who want to extend the time between visits without sacrificing results.
Botox Treatment Consultations Available
Xeomin
Xeomin (incobotulinumtoxinA), made by Merz, uses a purified formulation that strips away the accessory proteins found in other botulinum toxin products, delivering what’s sometimes called a “naked” toxin. Some patients who have developed resistance or a reduced response to other neuromodulators over time find that Xeomin restores a stronger effect. It’s also a strong option for patients with sensitivities who prefer a cleaner formulation.
So Which One Is Right for You?
The differences between these three products are real but nuanced. For most patients, all three deliver excellent results. The right choice depends on several factors:
- Treatment area: Some products spread out more than others, a bonus when treating larger areas like the forehead.
- How quickly you want results: Each product has its own schedule, so some may be better for you if you want to see results fast.
- Your history with neuromodulators: If you’ve been using one product for a while and it’s not working as well as it used to, switching may revive your results.
The best way to navigate these options is with a board-certified dermatologist who knows the products thoroughly and can match the right one to your anatomy, goals, and history. At Krauss Dermatology, every neuromodulator treatment starts with that conversation. Schedule a consultation to find the right fit.
Dr. Droms is a very good combination of being professional, friendly and patient. She answered all my questions and gave me a plan for going forward. I trust her judgement and would definitely recommend her!
Take the Next Step
If you have further questions about Botox alternatives like Dysport, Xeomin, Daxxify, and Jeuveau, we encourage you to schedule a consultation at Krauss Dermatology. Call us at (781) 247-5593 or fill out our online contact form. We look forward to taking care of you.
